€10.42
2.25%
Madrid, Mar 07, 05:35 pm CET
ISIN
ES0171996087
Symbol
GRF
Sector
Industry

Grifols Stock price

€10.42
+2.08 24.91% 1M
+1.12 12.07% 6M
+1.27 13.90% YTD
+3.49 50.27% 1Y
-6.43 38.14% 3Y
-17.95 63.27% 5Y
-8.03 43.52% 10Y
Madrid, Closing price Fri, Mar 07 2025
-0.24 2.25%
ISIN
ES0171996087
Symbol
GRF
Sector
Industry

Key metrics

Market capitalization €7.09b
Enterprise Value €18.94b
P/E (TTM) P/E ratio 45.05
P/B ratio (TTM) P/B ratio 1.21
Cash position €979.78m
P/E forward 14.20
P/S forward 0.92
EV/Sales forward 2.45

Is Grifols a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,808 stocks worldwide.

Grifols Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Grifols forecast:

10x Buy
67%
4x Hold
27%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Grifols forecast:

Buy
67%
Hold
27%
Sell
7%

Financial data from Grifols

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,976 1,976
12% 12%
100%
- Direct Costs 1,209 1,209
12% 12%
61%
766 766
11% 11%
39%
- Selling and Administrative Expenses 159 159
35% 35%
8%
- Research and Development Expense 115 115
1% 1%
6%
492 492
48% 48%
25%
- Depreciation and Amortization 110 110
1% 1%
6%
EBIT (Operating Income) EBIT 382 382
71% 71%
19%
Net Profit 69 69
23% 23%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Grifols directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Nacho Abia
Employees 23,833
Founded 1940
Website www.grifols.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today